Background: Despite serious concerns about the role of alteplase in the management of acute ischemic stroke including, but not limited to, significant conflicts of interest, unbalanced baseline patient characteristics, systematic devaluation of contrary data, lack of reproduced benefit and low ...
Background: Spontaneous, non-traumatic intracerebral hemorrhage, is one of the only stroke subtypes without a proven treatment. It is not as common as ischemic stroke, representing up to 20% of all strokes, but it accounts for almost half of all stroke deaths worldwide. ...
Background: Alteplase is a tissue plasminogen activator that is approved for use prior to thrombectomy in ischemic strokes with the goal of reperfusion to ischemic areas of the brain. Tenecteplase is a recombinant enzyme derived from alteplase that is more ...
Definition: Syndrome characterized by dysfunction of multiple lumbar and sacral nerve roots in the lumbar vertebral canal due to compression Anatomy The spinal cord terminates in the conus medullaris at the T12/L1 vertebral body in adults Cauda equina Collection of ...
With the publication of the DAWN and DEFUSE-3 trials came a new era in stroke management. We have discussed the specific literature pertaining to endovascular therapy on REBEL EM before in our 2hour CME activity HERE. Along with the two new publications ...
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
